Shandong Weigao (01066) Announces Share Repurchase and Updated Issued Shares

Bulletin Express01-21

Shandong Weigao Group Medical Polymer Company Limited (01066) submitted a Next Day Disclosure Return on 21 January 2026. According to the information disclosed, the company repurchased 180,000 H shares on 21 January 2026 at a highest repurchase price of HKD 5.16 and a lowest price of HKD 5.14, with an aggregate price paid of HKD 927,000.

Prior to this repurchase, the opening balance as of 20 January 2026 showed 4,484,668,724 issued shares (excluding treasury shares) and 37,663,600 treasury shares, for a total of 4,522,332,324 shares. After the transaction, the issued shares (excluding treasury shares) stood at 4,484,488,724, and treasury shares increased to 37,843,600. The total number of issued shares remained 4,522,332,324.

From the repurchase mandate resolution passed on 27 May 2025, the company was authorized to repurchase up to 451,560,392 shares. As of the date of the disclosure, a total of 31,195,200 shares have been repurchased under the mandate, accounting for approximately 6.9083% of the issued shares (excluding treasury shares) on the date of the resolution. The period prohibiting any new share issuance or transfer of treasury shares arising from this repurchase will last until 20 February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171841062?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171841062","market":"us","top_or_hot":-1,"title":"Shandong Weigao (01066) Announces Share Repurchase and Updated Issued Shares","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (01066) submitted a Next Day Disclosure Return on 21 January 2026. According to the information disclosed, the company repurchased 180,000 H shares on 21 January 2026 at a highest repurchase price of HKD 5.16 and a lowest price of HKD 5.14, with an aggregate price paid of HKD 927,000.</p>\n<p>Prior to this repurchase, the opening balance as of 20 January 2026 showed 4,484,668,724 issued shares (excluding treasury shares) and 37,663,600 treasury shares, for a total of 4,522,332,324 shares. After the transaction, the issued shares (excluding treasury shares) stood at 4,484,488,724, and treasury shares increased to 37,843,600. The total number of issued shares remained 4,522,332,324.</p>\n<p>From the repurchase mandate resolution passed on 27 May 2025, the company was authorized to repurchase up to 451,560,392 shares. As of the date of the disclosure, a total of 31,195,200 shares have been repurchased under the mandate, accounting for approximately 6.9083% of the issued shares (excluding treasury shares) on the date of the resolution. The period prohibiting any new share issuance or transfer of treasury shares arising from this repurchase will last until 20 February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Weigao (01066) Announces Share Repurchase and Updated Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Weigao (01066) Announces Share Repurchase and Updated Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-21 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (01066) submitted a Next Day Disclosure Return on 21 January 2026. According to the information disclosed, the company repurchased 180,000 H shares on 21 January 2026 at a highest repurchase price of HKD 5.16 and a lowest price of HKD 5.14, with an aggregate price paid of HKD 927,000.</p>\n<p>Prior to this repurchase, the opening balance as of 20 January 2026 showed 4,484,668,724 issued shares (excluding treasury shares) and 37,663,600 treasury shares, for a total of 4,522,332,324 shares. After the transaction, the issued shares (excluding treasury shares) stood at 4,484,488,724, and treasury shares increased to 37,843,600. The total number of issued shares remained 4,522,332,324.</p>\n<p>From the repurchase mandate resolution passed on 27 May 2025, the company was authorized to repurchase up to 451,560,392 shares. As of the date of the disclosure, a total of 31,195,200 shares have been repurchased under the mandate, accounting for approximately 6.9083% of the issued shares (excluding treasury shares) on the date of the resolution. The period prohibiting any new share issuance or transfer of treasury shares arising from this repurchase will last until 20 February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1171841062","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171841062","pubTimestamp":1768989863,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (01066) submitted a Next Day Disclosure Return on 21 January 2026. According to the information disclosed, the company repurchased 180,000 H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"山东威高(01066)公布购回股份及更新已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (01066) submitted a Next Day Disclosure Return on 21 January 2026. According to the information disclosed, the company repurchased 180,000 H shares on 21 January 2026 at a highest repurchase price of HKD 5.16 and a lowest price of HKD 5.14, with an aggregate price paid of HKD 927,000.\nPrior to this repurchase, the opening balance as of 20 January 2026 showed 4,484,668,724 issued shares (excluding treasury shares) and 37,663,600 treasury shares, for a total of 4,522,332,324 shares. After the transaction, the issued shares (excluding treasury shares) stood at 4,484,488,724, and treasury shares increased to 37,843,600. The total number of issued shares remained 4,522,332,324.\nFrom the repurchase mandate resolution passed on 27 May 2025, the company was authorized to repurchase up to 451,560,392 shares. As of the date of the disclosure, a total of 31,195,200 shares have been repurchased under the mandate, accounting for approximately 6.9083% of the issued shares (excluding treasury shares) on the date of the resolution. The period prohibiting any new share issuance or transfer of treasury shares arising from this repurchase will last until 20 February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171841062","isCrawlerRequest":true}